• Home
  1. Home
  2. Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore
Scientific article
English

Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore

Contributors

Hoda-Jourdan, Jean-Charles; Gu, Wenli; Friedli, Marc; Phillips, Hilary A.; Bertrand, Sonia; Antonarakis, Stylianos; Goudie, David; Roberts, Richard; Scheffer, Ingrid E.; Marini, Carla; Patel, Jayesh; Berkovic, Samuel F.; Mulley, John C.; Steinlein, Ortrud K.; Bertrand, Daniel

Published in

Molecular pharmacology, vol. 74, no. 2, p. 379-391

Publication date

2008

Abstract

Certain mutations in specific parts of the neuronal nicotinic acetylcholine receptor (nAChR) subunit genes CHRNA4, CHRNB2, and probably CHRNA2, can cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). All but one of the known causative mutations are located in the second transmembrane region (TM2), which serves as the major ion poreforming domain of the receptor. Functional characterization of these ADNFLE mutations has shown that although each mutant exhibits specific properties, they all confer a gain of function with increased sensitivity to acetylcholine. In this work, we characterize the second and third ADNFLE-associated mutations that are external to TM2 but affect different amino acid residues within the third transmembrane region (TM3). The two new CHRNB2 mutations were identified in three families of Turkish Cypriot, Scottish, and English origin. These TM3 mutations elicit the same gain of function pathomechanism as observed for the TM2 mutations with enhanced acetylcholine sensitivity, despite their unusual localization within the gene. Electrophysiological experiments, including single channel measurements, revealed that incorporation of these new mutant subunits does not affect the conductance of the ionic pore but increases the probability of opening. Determination of the sensitivity to nicotine for nAChRs carrying mutations in TM2 and TM3 showed clear differences in the direction and the extent to which the window current for nicotine sensitivity was shifted for individual mutations, indicating differences in pharmacogenomic properties that are not readily correlated with increased ACh affinity.

Keywords

  • Adolescent
  • Adult
  • Amino Acid Substitution/genetics
  • Animals
  • Anticonvulsants/pharmacology/therapeutic use
  • Cell Line
  • Epilepsy, Frontal Lobe/drug therapy/genetics/metabolism
  • Female
  • Humans
  • Ion Channelsbiosynthesis/genetics
  • Male
  • Mutation
  • Patch-Clamp Techniques
  • Pharmacogenetics/methods
  • Protein Subunits/biosynthesis/genetics
  • Receptors, Nicotinic/biosynthesis/genetics
  • Sleep Disorders/drug therapy/genetics/metabolism
  • Xenopus laevis

UNIGE affiliation entities

UNIGE research groups

Citation (ISO format)

HODA-JOURDAN, Jean-Charles et al. Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore. In: Molecular pharmacology, 2008, vol. 74, n° 2, p. 379–391. doi: 10.1124/mol.107.044545

Main files (1)

Article (Accepted version)

Identifiers

Additional URL for this publication

http://molpharm.aspetjournals.org/cgi/content/full/74/2/379

Journal ISSN

0026-895X
698views
0downloads

Technical informations

Creation

05/03/2009 15:49:00

First validation

05/03/2009 15:49:00

Update

26/03/2026 10:45:08

Status update

26/03/2026 10:45:08

Last indexation

26/03/2026 10:52:06
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated